• 목록

A New Horizon in Cancer Treatment!

International Cancer Care & Medical Sharing Conference to Be Held

On April 28–29, 2023, the International Virus Research Alliance (IVRA) will host the “2023 IVRA Hope for Cancer Treatment Conference”, in collaboration with the Korean Society of Hyperthermia in Medicine (President: Dr. Il-Bong Choi) and sponsored by AdipoLabs, Inc.. This international academic seminar is expected to attract over 1,000 participants, including overseas medical professionals, government officials, and renowned domestic experts in cancer treatment.

IVRA (International Virus Research Alliance), founded with the mission of addressing diseases such as coronavirus and overcoming humanity’s long-standing challenge of curing cancer, has been organizing the IVRA International Medical Conference annually since 2021.

In modern medicine, the standard cancer treatments are chemotherapy, radiotherapy, and surgery. High-frequency hyperthermia therapy has traditionally been regarded only as a supportive measure. However, IVRA has demonstrated that the Remission 1℃ high-frequency hyperthermia device not only treats cancer directly through heat but also activates the immune system through thermal stimulation, thereby providing a secondary therapeutic and preventive effect against cancer. Based on this, the upcoming conference will feature firsthand clinical case presentations by domestic and international physicians using hyperthermia devices, which are expected to significantly shift the perception of hyperthermia and bring meaningful change to the field of cancer treatment.

The event’s sponsor, AdipoLabs, Inc. (CEO: Sung-Ho Han), has supplied the Remission 1℃ hyperthermia device to more than 80 hospitals across Korea while also pioneering overseas markets. In particular, the company has donated the device to IVRA member countries. Recently, AdipoLabs signed an MOU with Cyberjaya University in Malaysia, strengthening its commitment to academic and clinical research, and concentrating efforts on the global standardization of hyperthermia therapy. The accumulated outcomes of these efforts will be presented at this international conference.

Participating institutions include:

• Catholic University of Korea, Seoul St. Mary’s Hospital Advanced Medical Research Institute
• Wonju Severance Christian Hospital
• Amilang Clinic
• Daejeon University Seoul Korean Medicine Hospital
• Chihyu Korean Medicine Hospital
• BioSyn Korea Co., Ltd.
• Red & Blue Co., Ltd.
• Korean Society of Hyperthermia in Medicine
• Korean Balance Medical Society
• Korean Emergency Medical Association

Keynote speakers and lecturers include:

• Dr. Il-Bong Choi (Korean Society of Hyperthermia in Medicine, Choice Choi Clinic)
• Dr. Hong-Seok Jang (Department of Radiation Oncology, Seoul St. Mary’s Hospital)
• Prof. Young-Nam Kang (Department of Radiation Oncology, Seoul St. Mary’s Hospital)
• Dr. Seung-Mo Yoo (Yesan Myongji Hospital)
• Drs. Hyuk-Jun Jang & Jae-Ho Yang (Chihyu Hospital)
• Dr. Si-Hyung Lee (Korea Institute of Natural Medicine)
• Dr. Seon-Man Kim (Amilang Clinic)
• Dr. Seok-Jae Choi (Amilang Clinic)

Cancer patients and their families are also welcome to attend, and registration is available via the link below.